
Moritz Peiseler
Articles
-
Jul 11, 2024 |
gut.bmj.com | Yuting Wang |Felix Heymann |Moritz Peiseler |Charité Universitätsmedizin Berlin
Your PrivacyWe process your data to deliver content or advertisements and measure the delivery of such content or advertisements to extract insights about our website. We share this information with our partners on the basis of consent and legitimate interest. You may exercise your right to consent or object to a legitimate interest, based on a specific purpose below or at a partner level in the link under each purpose.
-
May 22, 2024 |
gut.bmj.com | Yuting Wang |Felix Heymann |Moritz Peiseler |Charité Universitätsmedizin Berlin
Your PrivacyWe process your data to deliver content or advertisements and measure the delivery of such content or advertisements to extract insights about our website. We share this information with our partners on the basis of consent and legitimate interest. You may exercise your right to consent or object to a legitimate interest, based on a specific purpose below or at a partner level in the link under each purpose.
-
Sep 8, 2023 |
science.org | Xiangdong Lv |Moritz Peiseler |Guojun He |Adriano Aguzzi
There are no cures for the most common neurodegenerative diseases. None of the currently approved treatments cure or halt these conditions; rather, they address symptoms or slow disease progression. A focus on protein deposits in the brain—a hallmark of Alzheimer’s disease (AD) and Parkinson’s disease (PD)—has led to the development of immunotherapy drugs. Other promising avenues of investigation include the roles of neuroinflammation in neurodegeneration.
-
Sep 8, 2023 |
sciencemag.org | Xiangdong Lv |Moritz Peiseler |Guojun He |Bruna Araujo David
Published In ScienceVolume 381 | Issue 66628 September 2023Article versionsSubmission historyReceived: 13 April 2022Accepted: 13 July 2023Published in print: 8 September 2023PermissionsRequest permissions for this article. AcknowledgmentsWe thank L. Zbytnuik, M. Newton, and T. Nussbaumer for excellent technical support. We thank K. Poon for assistance with flow cytometry. We thank all current and past Kubes lab members for constant support and feedback. The authors thank L. Babes for help with IVM.
-
Sep 8, 2023 |
science.org | Xiangdong Lv |Moritz Peiseler |Guojun He |Bruna Araujo David
Published In ScienceVolume 381 | Issue 66628 September 2023Article versionsSubmission historyReceived: 13 April 2022Accepted: 13 July 2023Published in print: 8 September 2023PermissionsRequest permissions for this article. AcknowledgmentsWe thank L. Zbytnuik, M. Newton, and T. Nussbaumer for excellent technical support. We thank K. Poon for assistance with flow cytometry. We thank all current and past Kubes lab members for constant support and feedback. The authors thank L. Babes for help with IVM.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →